B-Cell Receptor Features and Database Establishment in Recovered COVID-19 Patients by Combining 5'-RACE with PacBio Sequencing

Zhu Zhu,Pingzhang Wang,Xiaodong Jia,Meng Yu,Huige Yan,Lei Liu,Wanbing Liu,Yaqiong Zheng,Guomei Kou,Jie Wang,Weiyan Xu,Jing Huang,Fugang Duan,Fengmin Lu,Ning Fu,Ning Zhang,Yingying Lu,Hui Dai,Shangen Zheng,Xiaoyan Qiu
DOI: https://doi.org/10.31083/j.fbl2802040
IF: 3.1
2023-02-28
Frontiers in Bioscience-Landmark
Abstract:BACKGROUND: Antibodies induced by viral infection can not only prevent subsequent virus infection, but can also mediate pathological injury following infection. Therefore, understanding the B-cell receptor (BCR) repertoire of either specific neutralizing or pathological antibodies from patients convalescing from Coronavirus disease 2019 (COVID-19) infection is of benefit for the preparation of therapeutic or preventive antibodies, and may provide insight into the mechanisms of COVID-19 pathological injury.METHODS: In this study, we used a molecular approach of combining 5' Rapid Amplification of cDNA Ends (5'-RACE) with PacBio sequencing to analyze the BCR repertoire of all 5 <i>IgH</i> and 2 <i>IgL</i> genes in B-cells harvested from 35 convalescent patients after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.RESULTS: We observed numerous BCR clonotypes within most COVID-19 patients, but not in healthy controls, which validates the association of the disease with a prototypical immune response. In addition, many clonotypes were found to be frequently shared between different patients or different classes of antibodies.CONCLUSIONS: These convergent clonotypes provide a resource to identify potential therapeutic/prophylactic antibodies, or identify antibodies associated with pathological effects following infection with SARS-CoV-2.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?